| Kelly Hall, MS, SLP | |
|
7615 Se 19th Ave, Portland, OR 97202-6206 | |
| (503) 799-8689 | |
| Not Available |
| Full Name | Kelly Hall |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7615 Se 19th Ave, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043693112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Hall, MS, SLP 7615 Se 19th Ave, Portland, OR 97202-6206 Ph: (503) 799-8689 | Kelly Hall, MS, SLP 7615 Se 19th Ave, Portland, OR 97202-6206 Ph: (503) 799-8689 |
News Archive
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Researchers have shown for the first time that Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease (MND) and schizophrenia have a shared genetic origin, indicating that the causes of these diverse conditions are biologically linked.
The ongoing coronavirus pandemic (COVID-19) has claimed more than 4.1 million lives worldwide. This pandemic is caused by a novel single-stranded RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first reported in 2019 in Wuhan, China. The rapid spread of this virus is attributed to its high infectiousness and its ability to escape and counteract host immune responses, e.g., autophagy.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
New research can enhance survival of islets transplants and improve treatment of type 1 diabetes. Transplantation of insulin-producing cell islets, so-called islets of langerhans is an appealing strategy for treatment of type 1 diabetes. But it turns out that these are short-lived, and the procedure needs to be repeated.
› Verified 6 days ago
Mira E Shah, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2855 Se 61st Avenue, Portland, OR 97206 Phone: 503-348-0931 | |
Hearing & Speech Institute Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1675 Sw Marlow Ave, Suite 200, Portland, OR 97225 Phone: 503-228-6479 Fax: 503-228-4248 | |
Dr. Philip J Levinson, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1507 Sw Morrison St, Suite A, Portland, OR 97205 Phone: 503-226-1048 Fax: 503-226-1049 | |
Katherine Rhodes, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 730 Ne 148th Ave, Portland, OR 97230 Phone: 503-262-9359 | |
Ms. Brenda Joy Nuckton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 0270 Sw Palatine Hill Rd, Portland, OR 97219 Phone: 503-236-4940 | |
Ms. Lauren Renee Zlott, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2711 Se 28th Ave, Portland, OR 97202 Phone: 530-921-2151 Fax: 971-206-5203 | |
Kelly Wonitowy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1406 Se 85th Ave, Portland, OR 97216 Phone: 971-227-0523 |